Jennifer Marshall

Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis

K. C. Morris, Mohammed Salah Ibrahim, K. Y. Wong, 2022, medRxiv.

Mitochondrial fission is increased in macrophages during mROS production in response to S. pneumoniae

P. Bullough, P. Shaw, K. D. De Vos, 2021, bioRxiv.

Macrophages utilize mitochondrial fission to enhance mROS production during responses to Streptococcus pneumoniae

P. Bullough, P. Shaw, K. D. De Vos, 2019 .

Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Steve B Jones, K. Y. Wong, Chamil H. Hettiarachchi, 2021, Lancet.

Opsonic Phagocytosis in Chronic Obstructive Pulmonary Disease Is Enhanced by Nrf2 Agonists

Richard D Emes, J. Wedzicha, Dave Singh, 2018, American journal of respiratory and critical care medicine.

Hippocampal Tissue of Patients with Refractory TLE is associated with Astrocyte Activation , Inflammation , and Altered Expression of Channels and Receptors

J. Edwards, L. Bonilha, N. Banik, 2012 .

Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial

K. C. Morris, Michele R. Shaw, Mohammed Salah Ibrahim, 2023, The Lancet.

Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

K. Y. Wong, Mohammad A. Qayum, John S. Clouston, 2022, Lancet.

Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial

K. Y. Wong, Beverley E. Crane, Scott M Elliott, 2021, Lancet.